Comparison of Clinical and Morphological Characteristics of Staphylococcus Aureus Endocarditis with Endocarditis Caused by Other Pathogens

Overview

Journal Heart

Date 2005 Jun 17

PMID 15958364

Citations 28

Authors

G Nadji

J P Remadi

F Coviaux

A Ali Mirode

A Brahim

M Enriquez-Sarano

C Tribouilloy

Affiliations

Soon will be listed here.

Abstract

Objectives: To analyse clinical, echocardiographic, and prognostic characteristics of Staphylococcus aureus infective endocarditis (IE) compared with endocarditis caused by other pathogens.

Design: Cohort study.

Methods: 194 consecutive patients with definite IE according to the Duke criteria prospectively examined by transthoracic and transoesophageal echocardiography were enrolled. Patients without identified microorganisms were excluded. The S aureus IE group (n = 61) was compared with the group with IE caused by other pathogens (n = 133).

Results: Compared with IE caused by other pathogens, S aureus IE was characterised by severe co-morbidity, a shorter duration of symptoms before diagnosis, and a higher prevalence of right sided IE, cutaneous portal of entry, and history of renal failure. Severe sepsis, major neurological events, and multiple organ failure were more frequent during the acute phase in S aureus IE. In-hospital mortality (34% v 10%, p < 0.001) was higher in patients with S aureus IE and the 36 month actuarial survival rate was lower in S aureus IE than in IE caused by other pathogens (47% v 68%, p = 0.002). Multivariate analyses identified S aureus infection as a predictive factor for in-hospital mortality and for overall mortality.

Conclusions: S aureus IE compared with IE caused by other pathogens occurs in a more debilitated clinical setting and is characterised by a higher prevalence of severe sepsis, major neurological events, and multiple organ failure leading to higher mortality.

Citing Articles

Infective endocarditis in a Finnish tertiary care hospital: from etiology to embolic events.

Ahtela E, Kyto V, Vahlberg T, Hohenthal U, Ekstrom T, Porela P Ann Med. 2024; 56(1):2415405.

PMID: 39520154 PMC: 11552265. DOI: 10.1080/07853890.2024.2415405.

endocarditis: Identifying prognostic factors using a method derived from morbidity and mortality conferences.

Lefevre B, Legoff A, Boutrou M, Goehringer F, Ngueyon-Sime W, Chirouze C Front Med (Lausanne). 2022; 9:1053278.

PMID: 36561723 PMC: 9763316. DOI: 10.3389/fmed.2022.1053278.

Neutrophils Protect Against Endocarditis Progression Independent of Extracellular Trap Release.

Meyers S, Lox M, Kraisin S, Liesenborghs L, Martens C, Frederix L Arterioscler Thromb Vasc Biol. 2022; 43(2):267-285.

PMID: 36453281 PMC: 9869964. DOI: 10.1161/ATVBAHA.122.317800.

Temporal trends in incidence, patient characteristics, microbiology and in-hospital mortality in patients with infective endocarditis: a contemporary analysis of 86,469 cases between 2007 and 2019.

Becher P, Gossling A, Fluschnik N, Schrage B, Seiffert M, Schofer N Clin Res Cardiol. 2022; 113(2):205-215.

PMID: 36094574 PMC: 10850016. DOI: 10.1007/s00392-022-02100-4.

Staphylococcus aureus increases platelet reactivity in patients with infective endocarditis.

Polzin A, Dannenberg L, MPembele R, Mourikis P, Naguib D, Zako S Sci Rep. 2022; 12(1):12933.

PMID: 35902612 PMC: 9334290. DOI: 10.1038/s41598-022-16681-7.

References

Gouello J, Asfar P, Brenet O, Kouatchet A, Berthelot G, Alquier P . Nosocomial endocarditis in the intensive care unit: an analysis of 22 cases. Crit Care Med. 2000; 28(2):377-82. DOI: 10.1097/00003246-200002000-00015. View

Watanakunakorn C, Burkert T . Infective endocarditis at a large community teaching hospital, 1980-1990. A review of 210 episodes. Medicine (Baltimore). 1993; 72(2):90-102. DOI: 10.1097/00005792-199303000-00003. View

Senni M, Merlo M, Sangiorgi G, Gamba A, Procopio A, Glauber M . Mitral valve repair and transesophageal echocardiographic findings in a high-risk subgroup of patients with active, acute infective endocarditis. J Heart Valve Dis. 2001; 10(1):72-7. View

Di Salvo G, Habib G, Pergola V, Avierinos J, Philip E, Casalta J . Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol. 2001; 37(4):1069-76. DOI: 10.1016/s0735-1097(00)01206-7. View

Cabell C, Jollis J, Peterson G, Corey G, Anderson D, Sexton D . Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med. 2002; 162(1):90-4. DOI: 10.1001/archinte.162.1.90. View

Hoen B, Alla F, Selton-Suty C, Beguinot I, Bouvet A, Briancon S . Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002; 288(1):75-81. DOI: 10.1001/jama.288.1.75. View

Petti C, Fowler Jr V . Staphylococcus aureus bacteremia and endocarditis. Infect Dis Clin North Am. 2002; 16(2):413-35, x-xi. DOI: 10.1016/s0891-5520(01)00003-4. View

Mouly S, Ruimy R, Launay O, Arnoult F, Brochet E, Leport C . The changing clinical aspects of infective endocarditis: descriptive review of 90 episodes in a French teaching hospital and risk factors for death. J Infect. 2002; 45(4):246-56. DOI: 10.1053/jinf.2002.1058. View

Ako J, Ikari Y, Hatori M, Hara K, Ouchi Y . Changing spectrum of infective endocarditis: review of 194 episodes over 20 years. Circ J. 2003; 67(1):3-7. DOI: 10.1253/circj.67.3. View

10.

Iung B, Rousseau-Paziaud J, Cormier B, Garbarz E, Fondard O, Brochet E . Contemporary results of mitral valve repair for infective endocarditis. J Am Coll Cardiol. 2004; 43(3):386-92. DOI: 10.1016/j.jacc.2003.09.034. View

11.

Shapiro S, Young E, de Guzman S, Ward J, Chiu C, Ginzton L . Transesophageal echocardiography in diagnosis of infective endocarditis. Chest. 1994; 105(2):377-82. DOI: 10.1378/chest.105.2.377. View

12.

Durack D, Lukes A, Bright D . New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994; 96(3):200-9. DOI: 10.1016/0002-9343(94)90143-0. View

13.

Watanakunakorn C . Staphylococcus aureus endocarditis at a community teaching hospital, 1980 to 1991. An analysis of 106 cases. Arch Intern Med. 1994; 154(20):2330-5. View

14.

Wolff M, WITCHITZ S, Chastang C, Regnier B, Vachon F . Prosthetic valve endocarditis in the ICU. Prognostic factors of overall survival in a series of 122 cases and consequences for treatment decision. Chest. 1995; 108(3):688-94. DOI: 10.1378/chest.108.3.688. View

15.

Aranki S, Adams D, Rizzo R, Couper G, SULLIVAN T, Collins Jr J . Determinants of early mortality and late survival in mitral valve endocarditis. Circulation. 1995; 92(9 Suppl):II143-9. DOI: 10.1161/01.cir.92.9.143. View

16.

Hogevik H, Olaison L, Andersson R, Lindberg J, ALESTIG K . Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study. Medicine (Baltimore). 1995; 74(6):324-39. DOI: 10.1097/00005792-199511000-00003. View

17.

Tribouilloy C, Ruiz V, Roudaut R, Eicher J, Denis B, Lusson J . [Outcome of cardiac valve ring abscesses after medical treatment: attempt to identify criteria of favorable prognosis]. Presse Med. 1996; 25(28):1276-80. View

18.

Roder B, Wandall D, Espersen F, Frimodt-Moller N, Skinhoj P, Rosdahl V . Neurologic manifestations in Staphylococcus aureus endocarditis: a review of 260 bacteremic cases in nondrug addicts. Am J Med. 1997; 102(4):379-86. DOI: 10.1016/s0002-9343(97)00090-9. View

19.

Robinson D, Fowler V, Sexton D, Corey R, Conlon P . Bacterial endocarditis in hemodialysis patients. Am J Kidney Dis. 1997; 30(4):521-4. DOI: 10.1016/s0272-6386(97)90311-5. View

20.

Roder B, Wandall D, Espersen F, Frimodt-Moller N, Skinhoj P, Rosdahl V . A study of 47 bacteremic Staphylococcus aureus endocarditis cases: 23 with native valves treated surgically and 24 with prosthetic valves. Scand Cardiovasc J. 1997; 31(5):305-9. DOI: 10.3109/14017439709069552. View